Koshinski Asset Management
TEVA icon

Koshinski Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Koshinski Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,934
Closed -$36.9K – 1829
2022
Q1 		$36.9K Hold
3,934
– – ﹤0.01% 1225
2021
Q4 		$31.5K Buy
3,934
+1,500
+62% +$13.5K ﹤0.01% 1313
2021
Q3 		$23.7K Buy
+2,434
New +$22.8K ﹤0.01% 1399
2016
Q1 		– Sell
-3,645
Closed -$239K – 244
2015
Q4 		$239K Buy
3,645
+100
+3% +$6.18K 0.17% 173
2015
Q3 		$210K Sell
3,545
-80
-2% -$5.19K 0.13% 208
2015
Q2 		$214K Buy
3,625
+1
+0% +$62 0.14% 214
2015
Q1 		$226K Hold
3,624
– – 0.15% 195
2014
Q4 		$208K Buy
+3,624
New +$202K 0.12% 217

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Koshinski Asset Management's TEVA Position: Q2 2022 in Review

Koshinski Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2022, closing a stake of 3,934 shares — an estimated $36.9K sold.

Koshinski Asset Management first reported a position in TEVA in Q4 2014 and held it in 8 quarters. The position peaked at $239K in Q4 2015. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2022.

  • Koshinski Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 3,934 Teva Pharmaceuticals shares in Q2 2022, an estimated $36.9K.
  • Koshinski Asset Management first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 8 quarters.
  • Koshinski Asset Management's Teva Pharmaceuticals position peaked at $239K in Q4 2015.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.